Evidence map›Paper›PMID 34070957›Full record

ReviewGenes2021

Transcriptome Profile Alterations with Carbon Nanotubes, Quantum Dots, and Silver Nanoparticles: A Review.

Cullen Horstmann, Victoria Davenport, Min Zhang, Alyse Peters, Kyoungtae Kim

Abstract readReview
In one paragraph

Review in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. CdSe/ZnS Quantum Dots' Impact on In Vitro Actin Dynamics.International journal of molecular sciences · 2024
    Article
  5. Article
  6. Interactions between Quantum Dots and G-Actin.International journal of molecular sciences · 2023
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cullen HorstmannDepartment of Biology, Missouri State University, 901 S National, Springfield, MO 65897, USA.
Victoria DavenportDepartment of Biology, Missouri State University, 901 S National, Springfield, MO 65897, USA.
Min ZhangDepartment of Biology, Missouri State University, 901 S National, Springfield, MO 65897, USA.
Alyse PetersDepartment of Biology, Missouri State University, 901 S National, Springfield, MO 65897, USA.
Kyoungtae KimDepartment of Biology, Missouri State University, 901 S National, Springfield, MO 65897, USA.ORCID 0000-0003-0896-9572

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Next-generation sequencing (NGS) technology has revolutionized sequence-based research. In recent years, high-throughput sequencing has become the method of choice in studying the toxicity of chemical agents through observing and measuring changes in transcript levels. Engineered nanomaterial (ENM)-toxicity has become a major field of research and has adopted microarray and newer RNA-Seq methods. Recently, nanotechnology has become a promising tool in the diagnosis and treatment of several diseases in humans. However, due to their high stability, they are likely capable of remaining in the body and environment for long periods of time. Their mechanisms of toxicity and long-lasting effects on our health is still poorly understood. This review explores the effects of three ENMs including carbon nanotubes (CNTs), quantum dots (QDs), and Ag nanoparticles (AgNPs) by cross examining publications on transcriptomic changes induced by these nanomaterials.

Indexed as

TranscriptomeAnimalsHumansMetal NanoparticlesNanotubes, CarbonQuantum DotsSilverToxicity TestsNanotubes, CarbonSilverAg nanoparticlescarbon nanotubesengineered nanomaterialsnext-generation sequencingquantum dotstranscriptomic

Identifiers

PMID34070957
PMCPMC8224664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.